RespireRx Pharmaceuticals (RSPI) Short Interest Ratio & Short Volume $0.0020 0.00 (-4.76%) As of 05/2/2025 03:32 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock RespireRx Pharmaceuticals Short Interest DataRespireRx Pharmaceuticals (RSPI) has a short interest of 166,600 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a 106.96% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 453,330 shares to cover all short positions.Current Short Interest166,600 sharesPrevious Short Interest80,500 sharesChange Vs. Previous Month+106.96%Dollar Volume Sold Short$333.20Short Interest Ratio0.1 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares949,464,000 sharesShort Percent of Float0.04%Today's Trading Volume251,000 sharesAverage Trading Volume453,330 sharesToday's Volume Vs. Average55% Short Selling RespireRx Pharmaceuticals? Sign up to receive the latest short interest report for RespireRx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRSPI Short Interest Over TimeRSPI Days to Cover Over TimeRSPI Percentage of Float Shorted Over Time RespireRx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/2025166,600 shares $333.20 +107.0%0.0%0.1 $0.00 1/31/202580,500 shares $193.20 No ChangeN/A0.2 $0.00 7/15/2024103,000 shares $113.30 +122.0%N/A0 $0.00 6/30/202446,400 shares $185.60 -76.5%N/A0 $0.00 6/15/2024197,500 shares $533.25 No ChangeN/A0 $0.00 5/15/20247,500 shares $6.75 -91.0%N/A0 $0.00 4/30/202483,700 shares $83.70 +280.5%N/A0 $0.00 4/15/202422,000 shares $19.80 -73.1%N/A0 $0.00 3/31/202481,700 shares $81.70 No ChangeN/A0 $0.00 2/29/202487,100 shares $95.81 No ChangeN/A0 $0.00 Get the Latest News and Ratings for RSPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RespireRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/202488,500 shares $123.90 +88,400.0%N/A0 $0.00 12/31/2023100 shares $0.09 No ChangeN/A0 $0.00 9/30/202329,900 shares $32.89 -24.5%N/A0 $0.00 9/15/202339,600 shares $51.48 +32.0%N/A0 $0.00 8/31/202330,000 shares $36.00 No ChangeN/A0 $0.00 7/15/202397,600 shares $175.68 No ChangeN/A0 $0.00 6/15/202314,100 shares $29.61 +127.4%N/A0 $0.00 5/31/20236,200 shares $31.00 -6.1%N/A0 $0.01 5/15/20236,600 shares $18.48 No ChangeN/A0 $0.00 4/15/202329,500 shares $88.50 No ChangeN/A0 $0.00 2/15/2023100 shares $0.43 -96.7%N/A0 $0.00 1/31/20233,000 shares $12.60 No ChangeN/A0 $0.00 11/30/20222,600 shares $14.56 No ChangeN/A0 $0.01 10/31/20227,600 shares $43.32 -3.8%N/A0 $0.01 10/15/20227,900 shares $74.26 No ChangeN/A0.1 $0.01 9/15/202213,000 shares $83.20 +333.3%N/A0.1 $0.01 8/31/20223,000 shares $21.30 -66.7%N/A0 $0.01 8/15/20229,000 shares $45.90 No ChangeN/A0 $0.01 7/15/20225,500 shares $20.90 -37.5%N/A0 $0.00 6/30/20228,800 shares $33.44 +183.9%N/A0 $0.00 6/15/20223,100 shares $15.50 -65.9%N/A0 $0.01 5/31/20229,100 shares $59.15 -37.2%N/A0 $0.01 5/15/202214,500 shares $79.75 No ChangeN/A0 $0.01 3/31/2022500 shares $5.00 -81.5%N/A0 $0.01 3/15/20222,700 shares $27.00 -64.9%N/A0 $0.01 2/28/20227,700 shares $127.05 +755.6%N/A0.1 $0.02 2/15/2022900 shares $13.50 No ChangeN/A0 $0.02 12/15/20211,900 shares $29.07 +18.8%N/A0 $0.02 11/30/20211,600 shares $20.80 No ChangeN/A0 $0.01 9/30/20214,600 shares $105.80 +84.0%N/A0 $0.02Elon’s Terrifying Warning Forces Trump To Take Action (Ad)Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...Get your free gold guide! 9/15/20212,500 shares $60.75 No ChangeN/A0 $0.02 8/13/202121,500 shares $539.65 No ChangeN/A0.1 $0.03 7/15/20213,300 shares $99.00 -87.5%N/A0 $0.03 6/30/202126,300 shares $959.95 +345.8%N/A0.1 $0.04 6/15/20215,900 shares $213.58 -81.2%N/A0 $0.04 5/28/202131,300 shares $1,283.30 No ChangeN/A0.1 $0.04 4/30/20219,900 shares $449.46 No ChangeN/A0 $0.05 3/15/202123,200 shares $1,136.80 +1,446.7%N/A0 $0.05 2/26/20211,500 shares $67.50 -70.0%N/A0 $0.05 2/12/20215,000 shares $195.00 No ChangeN/A0 $0.04 11/30/202029,000 shares $87.00 +28,900.0%N/A0 $0.00 11/15/2020100 shares $0.40 No ChangeN/A0 $0.00 10/15/2020200 shares $1.18 -99.7%N/A0 $0.01 9/30/202074,200 shares $400.68 No ChangeN/A0 $0.01 8/31/202012,500 shares $72.50 -93.6%N/A0 $0.01 8/14/2020196,100 shares $1,411.92 +1,682.7%N/A0 $0.01 7/31/202011,000 shares $79.20 -69.3%N/A0 $0.01 7/15/202035,800 shares $279.24 -56.8%N/A0 $0.01 6/30/202082,900 shares $530.56 No ChangeN/A0 $0.01 RSPI Short Interest - Frequently Asked Questions What is RespireRx Pharmaceuticals' current short interest? Short interest is the volume of RespireRx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of February 15th, traders have sold 166,600 shares of RSPI short. 0.04% of RespireRx Pharmaceuticals' shares are currently sold short. Learn More on RespireRx Pharmaceuticals' current short interest. What is a good short interest percentage for RespireRx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of RespireRx Pharmaceuticals' floating shares are currently sold short. Is RespireRx Pharmaceuticals' short interest increasing or decreasing? RespireRx Pharmaceuticals saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 166,600 shares, an increase of 107.0% from the previous total of 80,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does RespireRx Pharmaceuticals' short interest compare to its competitors? 0.04% of RespireRx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to RespireRx Pharmaceuticals: Indaptus Therapeutics, Inc. (1.02%), Traws Pharma, Inc. (2.06%), Genprex, Inc. (6.94%), Apollomics, Inc. (1.73%), Citius Pharmaceuticals, Inc. (8.57%), NeuroBo Pharmaceuticals, Inc. (1.14%), Biofrontera Inc. (0.70%), Mainz Biomed (2.40%), American Premium Mining Co. (0.00%), Lipella Pharmaceuticals Inc. (0.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), Strategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short RespireRx Pharmaceuticals stock? Short selling RSPI is an investing strategy that aims to generate trading profit from RespireRx Pharmaceuticals as its price is falling. RSPI shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RespireRx Pharmaceuticals? A short squeeze for RespireRx Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RSPI, which in turn drives the price of the stock up even further. How often is RespireRx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RSPI, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies INDP Short Squeeze TRAW Short Squeeze GNPX Short Squeeze APLM Short Squeeze CTXR Short Squeeze NRBO Short Squeeze BFRI Short Squeeze MYNZ Short Squeeze HIPH Short Squeeze LIPO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:RSPI) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RespireRx Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RespireRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.